Patterns and determinants of blood transfusion in intensive care in Sweden between 2010 and 2018: A nationwide, retrospective cohort study.
critical care
epidemiology
intensive care
transfusion
Journal
Transfusion
ISSN: 1537-2995
Titre abrégé: Transfusion
Pays: United States
ID NLM: 0417360
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
revised:
28
03
2022
received:
03
02
2022
accepted:
28
03
2022
pubmed:
1
6
2022
medline:
14
6
2022
entrez:
31
5
2022
Statut:
ppublish
Résumé
Intensive care unit (ICU) patients are transfused with blood products for a number of reasons, from massive ongoing hemorrhage, to mild anemia following blood sampling, combined with bone marrow depression due to critical illness. There's a paucity of data on transfusions in ICUs and most studies are based on audits or surveys. The aim of this study was to provide a complete picture of ICU-related transfusions in Sweden. We conducted a register based retrospective cohort study with data on all adult patient admissions from 82 of 84 Swedish ICUs between 2010 and 2018, as recorded in the Swedish Intensive Care Register. Transfusions were obtained from the SCANDAT-3 database. Descriptive statistics were computed, characterizing transfused and nontransfused patients. The distribution of blood use comparing different ICUs was investigated by computing the observed proportion of ICU stays with a transfusion, as well as the expected proportion. In 330,938 ICU episodes analyzed, at least one transfusion was administered for 106,062 (32%). For both red-cell units and plasma, the fraction of patients who were transfused decreased during the study period from 31.3% in 2010 to 24.6% in 2018 for red-cells, and from 16.6% in 2010 to 9.4% in 2018 for plasma. After adjusting for a range of factors, substantial variation in transfusion frequency remained, especially for plasma units. Despite continuous decreases in utilization, transfusions remain common among Swedish ICU patients. There is considerable unexplained variation in transfusion rates. More research is needed to establish stronger critiera for when to transfuse ICU patients.
Sections du résumé
BACKGROUND
Intensive care unit (ICU) patients are transfused with blood products for a number of reasons, from massive ongoing hemorrhage, to mild anemia following blood sampling, combined with bone marrow depression due to critical illness. There's a paucity of data on transfusions in ICUs and most studies are based on audits or surveys. The aim of this study was to provide a complete picture of ICU-related transfusions in Sweden.
METHODS
We conducted a register based retrospective cohort study with data on all adult patient admissions from 82 of 84 Swedish ICUs between 2010 and 2018, as recorded in the Swedish Intensive Care Register. Transfusions were obtained from the SCANDAT-3 database. Descriptive statistics were computed, characterizing transfused and nontransfused patients. The distribution of blood use comparing different ICUs was investigated by computing the observed proportion of ICU stays with a transfusion, as well as the expected proportion.
RESULTS
In 330,938 ICU episodes analyzed, at least one transfusion was administered for 106,062 (32%). For both red-cell units and plasma, the fraction of patients who were transfused decreased during the study period from 31.3% in 2010 to 24.6% in 2018 for red-cells, and from 16.6% in 2010 to 9.4% in 2018 for plasma. After adjusting for a range of factors, substantial variation in transfusion frequency remained, especially for plasma units.
CONCLUSION
Despite continuous decreases in utilization, transfusions remain common among Swedish ICU patients. There is considerable unexplained variation in transfusion rates. More research is needed to establish stronger critiera for when to transfuse ICU patients.
Identifiants
pubmed: 35638740
doi: 10.1111/trf.16942
pmc: PMC9328318
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1188-1198Informations de copyright
© 2022 The Authors. Transfusion published by Wiley Periodicals LLC on behalf of AABB.
Références
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Crit Care. 2010;14(3):R92
pubmed: 20497535
Transfusion. 2020 Nov;60(11):2529-2536
pubmed: 32964488
BMC Anesthesiol. 2015 Jun 09;15:86
pubmed: 26054337
Crit Care Med. 2018 Apr;46(4):577-585
pubmed: 29300236
Acta Anaesthesiol Scand. 2012 Oct;56(9):1073-7
pubmed: 22967196
Med J Aust. 2003 Feb 3;178(3):117-21
pubmed: 12558482
Crit Care. 2010;14(5):R185
pubmed: 20950434
Crit Care. 1999;3(2):57-63
pubmed: 11056725
Transfus Med. 2019 Apr;29 Suppl 1:6-12
pubmed: 29148106
Intensive Care Med. 2010 Jul;36(7):1138-46
pubmed: 20440603
Crit Care Med. 2007 Jul;35(7):1655-9
pubmed: 17522577
Crit Care. 2019 Sep 11;23(1):309
pubmed: 31511083
N Engl J Med. 2014 Oct 9;371(15):1381-91
pubmed: 25270275
Transfusion. 2020 Dec;60(12):2801-2806
pubmed: 32888222
Hematol Oncol Clin North Am. 2019 Oct;33(5):767-779
pubmed: 31466603
Eur J Epidemiol. 2009;24(11):659-67
pubmed: 19504049
Crit Care. 2018 Apr 19;22(1):102
pubmed: 29673409
Intensive Care Med. 2020 Apr;46(4):673-696
pubmed: 31912207
Transfusion. 2010 Apr;50(4):753-65
pubmed: 20003061
Transfusion. 2013 May;53(5):1050-8
pubmed: 22928908
Blood. 2008 Oct 1;112(7):2617-26
pubmed: 18809775
Transfusion. 2022 Jun;62(6):1188-1198
pubmed: 35638740
Crit Care Med. 2004 Jan;32(1):39-52
pubmed: 14707558
N Engl J Med. 1999 Feb 11;340(6):409-17
pubmed: 9971864
Crit Care. 2011;15(2):R108
pubmed: 21466676